Pharmacogenomics Testing: A Tool for Deprescribing in Long-Term Care

Presented by: Houda Hachad, Pharm D, M Res, Vice President of Clinical Operations, SinguLab

Date: Tuesday, December 12, 2023

Time: 1:00PM ET

As the number of older adults in the U.S. with complex health conditions rises, polypharmacy has also become commonplace. The additive and/or synergistic effects of multiple medications may have undesired impacts on a patient’s overall well-being, and these effects can potentially increase the risk of adverse events. Medication action plans and pharmacist-led interventions that focus on deprescribing can now be enhanced with genomics. While healthcare providers routinely rely on patient-specific factors to reduce the number of medications, utilizing a patient’s genomic information to enhance their care is not yet a standard practice. In this webinar, Dr. Hachad will discuss the utility of pharmacogenomics testing to guide efficacious deprescribing. She will discuss the benefits of testing for genetic variants that can help identify patients at risk for associated adverse drug events. She will also present when and how a patient’s pharmacogenomic signatures can help mitigate these risks and support deprescribing decisions in a geriatric population for commonly used medication classes.

Learning Objectives:

1. Identify the established pharmacogenomics associations for medications that are commonly co-prescribed in a geriatric population.
2. Illustrate clinical scenarios utilizing pharmacogenomic signatures to inform deprescribing.
3. Assess for common challenging geriatric syndromes that are exacerbated by select drug-to-gene interactions.
4. Describe how a pharmacogenomics program can promote safe and rational deprescribing to mitigate preventable negative outcomes.

This program was approved for 1 participant CE credit hour by NAB/NCERS, approval #20241211-1-A98160-DL. Attendees must have been in attendance for at least 50 minutes to receive credit.

Listen to the Recording